2025年全球药物输送系统市场报告

预计未来几年，药物输送系统市场规模将强劲成长；预计2029年将达到586.4亿美元，复合年增长率为7.3%。预测期内，推动这一增长的主要因素包括：对个人化医疗的日益关注、复杂敏感药物的研发管线不断扩大、罕见疾病和孤儿病患病率的上升、对创新输送技术的支持性法律规范以及老年人口的增长。预计这一时期的主要趋势包括：基于奈米技术的药物输送系统的发展、控释和控制释放缓释性的创新、需要特殊输送方法的生技药品和生物仿製药的进步、智能药物输送设备的集成以及针对肿瘤学的靶向输送解决方案的开发。

呼吸系统疾病盛行率的上升预计将在未来几年推动药物传输系统市场的成长。呼吸系统疾病是指破坏肺部和气道正常功能的疾病，会导致呼吸困难和氧气摄取量减少。此类疾病的增加主要是由于空气污染的加剧，空气污染使人们暴露在有害的空气颗粒和气体中，损害肺功能并导致呼吸系统疾病的发生和发展。药物输送系统在有效治疗和管理气喘、慢性阻塞性肺病(COPD)、肺纤维化和囊肿纤维化等呼吸系统疾病方面发挥着至关重要的作用。这些系统能够将药物直接输送到肺部，提高治疗效果，同时减少全身副作用。例如，2025 年 3 月，英国英国机构健康安全局报告称，2024 年英格兰的结核病病例将增加 13%，从 2023 年的 4,850 例增至 5,480 例。因此，呼吸系统疾病盛行率的上升预计将推动药物输送系统市场的发展。

药物输送系统市场的主要参与者正致力于开发先进的解决方案，例如无金属多剂量鼻喷泵，以提高使用者的舒适度和易用性。这些无金属多剂量鼻喷泵旨在透过鼻腔途径输送多剂量药物，无需加入金属部件，确保安全性并与各种剂型相容。例如，2023 年 1 月，美国製药公司 Aptar Pharma 推出了 APF Futurity 无金属多剂量鼻喷剂帮浦。该设备专门设计用于输送生理食盐水水和类似的非处方产品，并专注于可回收性。这是 Aptar Pharma 首款高度可回收的滴鼻剂泵，获得了欧洲回收标准 cyclos-HTP 的 AA 级认证。它完全由聚烯材料製成，不含金属部件或回收污染物，更易于回收并提高了回收材料的品质。这款无金属帮浦采用 Aptar Pharma 的先进无防腐剂技术，可提供准确、一致的剂量和平稳的运行，保持易用性和功效。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球药物输送系统：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球药物输送系统市场：成长率分析
• 全球药物传输系统市场表现：规模与成长，2019-2024
• 全球药物输送系统市场预测：规模与成长，2024-2029，2034
• 全球药物输送系统：总目标市场（TAM）

第六章市场区隔

• 全球药物输送系统市场类型、表现及预测（2019-2024、2024-2029、2034）
• 注射给药系统
• 口服给药系统
• 吸入或肺部给药系统
• 粘膜给药系统
• 全球药物输送系统市场（依材料、效能及预测），2019-2024 年、2024-2029 年、2034 年
• 聚合物基药物传输系统
• 脂质基药物传输系统
• 无机药物输送系统
• 生物製药传输系统
• 混合药物输送系统
• 全球药物传输系统市场的应用、效能及预测（2019-2024、2024-2029、2034）
• 感染疾病
• 肿瘤学
• 眼科
• 泌尿系统
• 糖尿病
• 中枢神经系统
• 其他用途
• 全球药物传输系统市场（依最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
• 医院
• 製药公司
• 研究所
• 居家照护环境
• 诊断实验室
• 全球药物传递系统市场，依注射式药物输送系统类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 静脉注射（IV）
• 肌肉注射（IM）
• 皮下（SC）
• 皮内
• 椎管内
• 长效注射
• 无针注射器
• 全球药物传递系统市场，依口服药物传递系统类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 药片
• 胶囊
• 溶液和糖浆
• 暂停
• 粉末和颗粒
• 控制释放製剂
• 全球药物输送系统市场，按吸入或肺部药物输送系统类型细分，性能和预测，2019-2024 年、2024-2029 年、2034 年
• 定量喷雾吸入器（MDI）
• 干粉吸入器（DPI）
• 喷雾器
• 缓雾吸入器
• 鼻喷剂
• 全球药物传递系统市场，依粘膜药物传递系统类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 口服
• 舌下
• 直肠分娩
• 阴道分娩
• 鼻黏膜递送

第七章 区域和国家分析

• 全球药物输送系统市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球药物输送系统市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 药物输送系统市场：竞争格局
• 药物输送系统市场：公司简介
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Bayer AG
• Sanofi SA
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott Laboratories Inc.
• Novartis AG
• GlaxoSmithKline PLC
• Eli Lilly and Company
• Amgen Inc.
• Becton, Dickinson and Company
• Teva Pharmaceutical Industries Ltd.
• Boston Scientific Corporation
• Tandem Diabetes
• Pacira Biosciences
• Poseida Therapeutics

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029年药物输送系统市场：提供新机会的国家
• 2029年药物输送系统市场：细分市场带来新机会
• 2029年药物传输系统市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Drug delivery systems are innovative technologies or methods developed to transport therapeutic agents within the body in a controlled and efficient way. These systems are designed to improve treatment effectiveness and safety by controlling the rate, timing, and location of drug release. They help maintain optimal drug concentrations at target sites, minimize side effects, and enhance patient adherence to prescribed treatments.

The primary categories of drug delivery systems include injection-based drug delivery systems, oral drug delivery systems, inhalation or pulmonary drug delivery systems, and transmucosal drug delivery systems. Injection-based drug delivery systems are medical devices used to administer drugs into the body via various injection routes, utilizing tools such as syringes, needles, or auto-injectors for precise and targeted delivery. These systems can be made from different material types, including polymer-based, lipid-based, inorganic, biologics-based, and hybrid drug delivery systems. They are used to treat conditions such as infectious diseases, cancer, eye disorders, urinary diseases, diabetes, central nervous system disorders, and more. Key end-users of these systems include hospitals, pharmaceutical companies, research institutions, homecare providers, and diagnostic laboratories.

The drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides drug delivery systems market statistics, including drug delivery systems industry global market size, regional shares, competitors with a drug delivery systems market share, detailed drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the drug delivery systems industry. This drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug delivery system market size has grown strongly in recent years. It will grow from $41.17 billion in 2024 to $44.21 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth during the historic period can be attributed to increasing investments in research and development, a surge in chronic disease prevalence, the expansion of biologics and monoclonal antibodies, rising demand for non-invasive drug delivery methods, and the growing need to enhance patient compliance and adherence.

The drug delivery system market size is expected to see strong growth in the next few years. It will grow to $58.64 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The projected growth in the forecast period can be attributed to an increased emphasis on personalized medicine, a growing pipeline of complex and sensitive pharmaceuticals, a rising prevalence of rare and orphan diseases, supportive regulatory frameworks for innovative delivery technologies, and an expanding geriatric population. Key trends expected during this period include the advancement of nanotechnology-based drug delivery systems, innovations in controlled-release and sustained-release mechanisms, progress in biologics and biosimilars that require specialized delivery methods, the integration of smart drug delivery devices, and the development of targeted delivery solutions specifically for oncology.

The rising prevalence of respiratory disorders is expected to drive the growth of the drug delivery systems market in the coming years. Respiratory disorders are conditions that disrupt the normal function of the lungs and airways, causing breathing difficulties and reduced oxygen intake. The increase in these disorders is largely due to escalating air pollution, which exposes people to harmful airborne particles and gases that damage lung function and contribute to the onset and progression of respiratory diseases. Drug delivery systems play a vital role in the effective treatment and management of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis. These systems enable medications to be delivered directly to the lungs, improving therapeutic effectiveness while reducing systemic side effects. For example, in March 2025, the UK Health Security Agency-a government body in the UK-reported that tuberculosis cases in England rose by 13% in 2024, increasing from 4,850 cases in 2023 to 5,480 cases. Consequently, the growing prevalence of respiratory disorders is expected to propel the drug delivery systems market.

Key players in the drug delivery systems market are concentrating on developing advanced solutions like metal-free, multidose nasal spray pumps to enhance user comfort and ease of use. These metal-free, multidose nasal spray pumps are designed to administer multiple medication doses through the nasal route without incorporating any metal parts, ensuring safety and compatibility with various formulations. For example, in January 2023, Aptar Pharma, a pharmaceutical company based in the U.S., introduced the APF Futurity metal-free, multidose nasal spray pump. This device is specifically engineered for delivering nasal saline and similar over-the-counter products, with a strong emphasis on recyclability. It is Aptar Pharma's first highly recyclable nasal spray pump, earning a Class AA certification from cyclos-HTP for European recycling standards. Constructed entirely from polyolefin materials and free from metal components or recycling contaminants, it facilitates easier recycling and enhances the quality of recycled materials. Incorporating Aptar Pharma's Advanced Preservative Free technology, this metal-free pump provides precise and consistent dosing with smooth operation, maintaining ease of use and effectiveness.

In January 2024, Kindeva Drug Delivery, a U.S.-based contract development and manufacturing organization, acquired Summit Biosciences Inc. for an undisclosed sum. This acquisition expanded Kindeva's drug delivery capabilities by adding a new platform. It enables the company to provide biopharmaceutical clients with a broader portfolio of advanced drug-device combination products, including those for pulmonary, injectable, transdermal, and nasal delivery. Summit Biosciences Inc. is a U.S.-based contract development and manufacturing firm specializing in intranasal drug delivery.

Major players in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Tandem Diabetes, Pacira Biosciences, Poseida Therapeutics, Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., VasoRx Inc.

North America was the largest region in the drug delivery system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in drug delivery systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug delivery systems market consists of sales of implantable devices, targeted delivery carriers, nanoparticle-based systems, and bio adhesive systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Delivery Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Injection-Based Drug Delivery System; Oral Drug Delivery System; Inhalation Or Pulmonary Drug Delivery System; Transmucosal Drug Delivery System
• 2) By Material: Polymer-Based Drug Delivery Systems; Lipid-Based Drug Delivery Systems; Inorganic Drug Delivery Systems; Biologics-Based Drug Delivery Systems; Hybrid Drug Delivery Systems
• 3) By Application: Infectious Disease; Oncology; Ophthalmology; Urology; Diabetes; Central Nervous System; Other Applications
• 4) By End-User: Hospitals; Pharmaceutical Companies; Research Institutions; Homecare Settings; Diagnostic Laboratories
• Subsegments:
• 1) By Injection-Based Drug Delivery System: Intravenous (IV); Intramuscular (IM); Subcutaneous (SC); Intradermal; Intrathecal; Depot Injections; Needle-Free Injectors
• 2) By Oral Drug Delivery System: Tablets; Capsules; Solutions And Syrups; Suspensions; Powders And Granules; Modified Release Formulations
• 3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizers; Soft Mist Inhalers; Nasal Sprays
• 4) By Transmucosal Drug Delivery System: Buccal Delivery; Sublingual Delivery; Rectal Delivery; Vaginal Delivery; Nasal Mucosal Delivery
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Delivery Systems Market Characteristics

3. Drug Delivery Systems Market Trends And Strategies

4. Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Drug Delivery Systems Growth Analysis And Strategic Analysis Framework

• 5.1. Global Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Drug Delivery Systems Market Growth Rate Analysis
• 5.4. Global Drug Delivery Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Drug Delivery Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Drug Delivery Systems Total Addressable Market (TAM)

6. Drug Delivery Systems Market Segmentation

• 6.1. Global Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injection-Based Drug Delivery System
• Oral Drug Delivery System
• Inhalation Or Pulmonary Drug Delivery System
• Transmucosal Drug Delivery System
• 6.2. Global Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymer-Based Drug Delivery Systems
• Lipid-Based Drug Delivery Systems
• Inorganic Drug Delivery Systems
• Biologics-Based Drug Delivery Systems
• Hybrid Drug Delivery Systems
• 6.3. Global Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease
• Oncology
• Ophthalmology
• Urology
• Diabetes
• Central Nervous System
• Other Applications
• 6.4. Global Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Pharmaceutical Companies
• Research Institutions
• Homecare Settings
• Diagnostic Laboratories
• 6.5. Global Drug Delivery Systems Market, Sub-Segmentation Of Injection-Based Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous (IV)
• Intramuscular (IM)
• Subcutaneous (SC)
• Intradermal
• Intrathecal
• Depot Injections
• Needle-Free Injectors
• 6.6. Global Drug Delivery Systems Market, Sub-Segmentation Of Oral Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Solutions And Syrups
• Suspensions
• Powders And Granules
• Modified Release Formulations
• 6.7. Global Drug Delivery Systems Market, Sub-Segmentation Of Inhalation or Pulmonary Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metered Dose Inhalers (MDIs)
• Dry Powder Inhalers (DPIs)
• Nebulizers
• Soft Mist Inhalers
• Nasal Sprays
• 6.8. Global Drug Delivery Systems Market, Sub-Segmentation Of Transmucosal Drug Delivery System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Buccal Delivery
• Sublingual Delivery
• Rectal Delivery
• Vaginal Delivery
• Nasal Mucosal Delivery

7. Drug Delivery Systems Market Regional And Country Analysis

• 7.1. Global Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Delivery Systems Market

• 8.1. Asia-Pacific Drug Delivery Systems Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Delivery Systems Market

• 9.1. China Drug Delivery Systems Market Overview
• 9.2. China Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Delivery Systems Market

• 10.1. India Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Delivery Systems Market

• 11.1. Japan Drug Delivery Systems Market Overview
• 11.2. Japan Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Delivery Systems Market

• 12.1. Australia Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Delivery Systems Market

• 13.1. Indonesia Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Delivery Systems Market

• 14.1. South Korea Drug Delivery Systems Market Overview
• 14.2. South Korea Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Delivery Systems Market

• 15.1. Western Europe Drug Delivery Systems Market Overview
• 15.2. Western Europe Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Delivery Systems Market

• 16.1. UK Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Delivery Systems Market

• 17.1. Germany Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Delivery Systems Market

• 18.1. France Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Delivery Systems Market

• 19.1. Italy Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Delivery Systems Market

• 20.1. Spain Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Delivery Systems Market

• 21.1. Eastern Europe Drug Delivery Systems Market Overview
• 21.2. Eastern Europe Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Delivery Systems Market

• 22.1. Russia Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Delivery Systems Market

• 23.1. North America Drug Delivery Systems Market Overview
• 23.2. North America Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Delivery Systems Market

• 24.1. USA Drug Delivery Systems Market Overview
• 24.2. USA Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Delivery Systems Market

• 25.1. Canada Drug Delivery Systems Market Overview
• 25.2. Canada Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Delivery Systems Market

• 26.1. South America Drug Delivery Systems Market Overview
• 26.2. South America Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Delivery Systems Market

• 27.1. Brazil Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Delivery Systems Market

• 28.1. Middle East Drug Delivery Systems Market Overview
• 28.2. Middle East Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Delivery Systems Market

• 29.1. Africa Drug Delivery Systems Market Overview
• 29.2. Africa Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Drug Delivery Systems Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Delivery Systems Market Competitive Landscape And Company Profiles

• 30.1. Drug Delivery Systems Market Competitive Landscape
• 30.2. Drug Delivery Systems Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Drug Delivery Systems Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca PLC
• 31.5. Abbott Laboratories Inc.
• 31.6. Novartis AG
• 31.7. GlaxoSmithKline PLC
• 31.8. Eli Lilly and Company
• 31.9. Amgen Inc.
• 31.10. Becton, Dickinson and Company
• 31.11. Teva Pharmaceutical Industries Ltd.
• 31.12. Boston Scientific Corporation
• 31.13. Tandem Diabetes
• 31.14. Pacira Biosciences
• 31.15. Poseida Therapeutics

32. Global Drug Delivery Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Delivery Systems Market

34. Recent Developments In The Drug Delivery Systems Market

35. Drug Delivery Systems Market High Potential Countries, Segments and Strategies

• 35.1 Drug Delivery Systems Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Drug Delivery Systems Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Drug Delivery Systems Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer